NCT05771090View on ClinicalTrials.gov

First Clinical Evaluation of a Novel Glucose Non-invasive Sensor Technology in Patients With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

June 16, 2023

Study Completion Date

June 16, 2023

Conditions
Diabetes Mellitus
Interventions
DEVICE

Sokru device

Different induced glycaemic states in people living with diabetes (PwD).

Trial Locations (1)

3010

Universitätsklinik für Diabetologie, Endokrinologie, Ernährungsmedizin & Metabolismus (UDEM) Inselspital, Universitätsspital, Bern

Sponsors

Lead Sponsor

DCB Research AG
All Listed Sponsors
collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

lead

DCB Research AG

OTHER